03:10 AM EDT, 10/17/2024 (MT Newswires) -- Michael J. LaBarre, Chief Technical Officer & Senior Vice President, on October 15, 2024, sold 20,000 shares in Halozyme Therapeutics ( HALO ) for $1,070,059. Following the Form 4 filing with the SEC, LaBarre has control over a total of 173,756 shares of the company, with 173,756 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1159036/000141588924025233/xslF345X05/form4-10162024_101045.xml

Price: 53.01, Change: -0.45, Percent Change: -0.84